Augmenticon Receives ISO 9001 Certification

Zurich, Switzerland – AUGMENTICON AG, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools, announces the certification of its quality management system by TUV Rheinland according to the ISO 9001:2015 standard. Augmenticon’s decision to work towards the ISO 9001:2015 standard was driven by more than 20 years of experience with pharmaceutical quality management systems and a firm commitment to continually improving our products and services.

“Achieving ISO 9001:2015 certification is fantastic news and means our customers have complete assurance that our products operate to the highest quality standard and our services meet their expectations reliably and consistently .” says Matthias Friebe, President of the Board of Directors.

Christian Schmidt, Chief Compliance Officer of AUGMENTICON states: “I am extremely proud of my team for their achievement, which proves our commitment to ensuring quality and providing the best possible service to our clients. We are dedicated to constant improvement and development. Achieving and maintaining an ISO 9001:2015 accreditation ensures that we have the processes and systems in place for this.”

Click here to download Augmenticon’s ISO 9001 certificate and Quality Policy.

About AUGMENTICON SHARE / ASSYST – The AR-/MR supported technology enables a fully remote-controlled installation, repair, and maintenance support, reduced response-times, lower costs (e.g. travel & accommodation etc.), and full online documentation. Furthermore, the technology brings a high potential for online-training, thus helps to shorten training time, and ensures smooth radio-labeling w/o batch failures.

About AUGMENTICON – AUGMENTICON, a driver in the application of novel INDUSTRY-4.0 solutions offers applications for the optimization of industrial radiopharmaceutical operations. The company, founded in 2019, is based in Glattbrugg/Switzerland and is developing and commercializing Augmented-/Mixed-Reality based tools for a fully remote-controlled manufacturing guidance, -control, and (GMP-)-documentation. It`s management has a combined 60+ years of expertise in the development, manufacturing, release, marketing, and commercialization of (radio-) pharmaceuticals. To learn more about AUGMENTICON please visit us at: https://www.augmenticon.ch.

InnoSuisse and Augmenticon fund AR-/MR-Technology Project

AUGMENTICON™ enters into a collaboration with the Center for Radiopharmaceutical Sciences, D-CHAB at ETH-Zurich and the Institute of Interactive Technologies at FHNW-Windisch to develop AR & mixed reality tools to extend AUGMENTICON`s SHARE and ASSYST platform technology. The project is jointly funded by the Swiss Innovation Agency, Innosuisse, and AUGMENTICON™.

Zurich, Switzerland – AUGMENTICON™ a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the formation of a strategic, non-exclusive development partnership with the ETH-Zürich (Center for Radiopharmaceutical Sciences, D-CHAB)) and the FHNW (Institute of Interactive Technologies – IIT) to expand functionalities and develop Tailored-Applications for AUGMENTICON`s SHARE- and ASSYST-platforms. The goals are to enhance technology transfer processes, improve manufacturing reliability, and further expand quality management/ auditing capabilities.

“Just-in-time” manufacturing and quality control of (radio-)pharmaceuticals, a key-element in this business area, does not tolerate human errors and requires equipment failures to be minimized. Stringent process-/equipment-monitoring and real-time feedback-features preventing operator errors and equipment failures are integral components of AUGMENTICON`s SHARE and ASSYST platforms. Next level applications / tools for such process control and documentation are the target of the project and are to be developed by the academic project partner, IIT. Requirement definition, continuous robustness testing and the implementation of routine application are performed in collaboration with the Center for Radiopharmaceutical Sciences at the ETHZ. The private-public partnership is supported by an R&D grant from the InnoSuisse (Swiss Agency for Innovation Funding). The major project goal is to further strengthen the Radiopharmacy industry’s capabilities to increase manufacturing process-reliability, quality-control & quality management excellence, as well as establish fully automated radiopharmaceutical process documentation.

“We are honored to be part of this exciting and forward-looking research project. Together with our partners, we are investigating ways in which Mixed Reality can sustainably improve the production of pharmaceuticals. We believe in it’s high potential and hope for a breakthrough by combining visual computing methods and intelligent embodied learning approaches.” – says Professor Doris Agotai, Head of IIT.

”We are excited to be part of this ambitious project together with the FHNW and AUGMENTICON™. The Center for Radiopharmaceutical Science (CRS) is a pioneer in translational, radiopharmaceutical research in Switzerland. CRS is always eager to develop, test and apply the newest technologies. We are convinced that with AUGMENTICON`s SHARE and ASSYST platforms and the experience and know-how of CRS we will change the way radiopharmaceuticals are developed and produced in the future.” – says Professor Roger Schibli, Head of Center for Radiopharmaceutical Sciences, D-CHAB.

Matthias Friebe, Executive Managing Director of AUGMENTICON states: “We are thrilled to enter into this private/public development partnership to provide top-notch Industry-4.0 tools for the pharmaceutical industry. It is a privilege for us to work with the leading scientists in the field and to leverage on innovation made in Switzerland”.

About AUGMENTICON-SHARE/ASSYST – The AR-/MR supported technology enables a fully remote-controlled installation, repair, and maintenance support, reduced response-times, lower costs (e.g. travel & accommodation etc.), and full online documentation. Furthermore, the technology brings a high potential for online-training, thus helps to shorten training time, and ensures smooth radio-labeling w/o batch failures.

About FHNW-Windisch, Institute of Interactive Technologies (IIT) – The Institute of Interactive Technologies IIT is a multidisciplinary computer science institute with research focusing on UX Design & Development, Interactive Data Visualization, Visual Analytics and Immersive Technologies. Ongoing research projects explore among others novel mixed reality environments based on image recognition and multimodal interaction. http://www.fhnw.ch/technik/iit

About ETH-Zurich, The Center for Radiopharmaceutical Sciences (CRS) – ETH Zurich belongs to the best universities in the world and is the leading university in continental Europe. In its role as a pioneering institution, it plays its part in ensuring that Switzerland will be able to hold its own on the global stage. The Center for Radiopharmaceutical Sciences (CRS) is a joint endeavor between the ETH Zurich, the Paul Scherrer Institut (PSI), and the University Hospital Zurich. CRS is integral towards the success of a “bench-to-bedside” venture for radiopharmaceuticals, utilizing specific know-how, infrastructures and unique facilities at the ETH Zurich and PSI including a dedicated medical cyclotron and clean rooms for the aseptic preparation of radiopharmaceuticals.

About AUGMENTICON™ – AUGMENTICON GmbH, a driver in the application of novel INDUSTRY-4.0 solutions offers applications for the optimization of industrial radiopharmaceutical operations. The company, founded in 2019, is based in Glattbrugg/Switzerland and is developing and commercializing Augmented-/Mixed-Reality based tools for a fully remote-controlled manufacturing guidance, -control, and (GMP-)-documentation. It`s management has a combined 60+ years of expertise in the development, manufacturing, release, marketing, and commercialization of (radio-) pharmaceuticals. To learn more about AUGMENTICON please visit us at: https://www.augmenticon.ch.

Friedrich Gause joins AUGMENTICON

Friedrich Gause joins AUGMENTICON as Senior Vice President Finance & Strategy Development

Zurich, Switzerland – AUGMENTICONTM, a privately held Augmented-/Mixed-Reality (AR/MR-)Technology company, developing novel tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the appointment of Friedrich Gause as its Senior Vice President Finance and Strategy Development.

Mr. Gause will take care of developing AUGMENTICON’s corporate and business strategy and implementation plans. In this context, he will oversee and facilitate related funding rounds, investment and partnering projects of the company with a particular attention to the fast-growing Asia/Pacific region.

“We are extremely pleased that Friedrich accepted to support AUGMENTICON in its startup operations in addition to his other entrepreneurial commitments” says Matthias Friebe, Co-Founder and CEO of AUGMENTICON.

During the past 30 years, Mr. Gause held various executive positions in the pharmaceutical industry, both in Europe and in the APAC region. At this stage, he holds positions as the Managing Director or BGM Associates GmbH, and as the Chairmen of the Board of Medicinisto AG.

About AUGMENTICONTM AUGMENTICON, a driver in the application of novel INDUSTRY-4.0 solutions offers applications for the optimization of industrial radiopharmaceutical operations. The company, founded in 2019, is based in Glattbrugg/Switzerland and is developing Augmented-/Mixed-Reality based tools for a fully remote-controlled manufacturing guidance, -control, and (GMP-)documentation. It`s management has a combined 60+ years of expertise in the development, manufacturing, release, marketing, and commercialization of (radio-)pharmaceuticals. To learn more about AUGMENTICON please visit us at: www.augmenticon.ch.

AUGMENTICON SHARE™ Version 5.2 Released

In response to the Covid-19 pandemic and an increased demand in remote support our IT developers have focused on improving the video call in the web application. The main improvements are:

  • Option to preselect the camera before starting the video call
  • Option to preselect the microphone before starting the video call
  • Troubleshooting Guide for Video and Audio
  • Changing the camera during video call
  • Changing the microphone during the video call
  • Improved user interfac of the functionalities in video call

The robust and convenient video call experience on smart glasses, smart phones, and tablets remains unaffected from these changes.